controlling cancer. This includes, for the first time, making pure vaccines to test against cancers that appear to respond better to immune manipulation than chemotherapy , such as malignant melanoma.
The architects of the U.S. National Cancer Act should be proud of what has been accomplished. It has been a long and arduous trip to this point, and although there is still a lot of work ahead of us, it is becoming increasingly apparent that the cancer cell is a vulnerable target and there is much room for optimism.
It is possible to begin to think of a world without cancer.
